Biodexa Pharmaceuticals Stock Surges 69% Over Partnership With Syngene International

(RTTNews) - Shares of Biodexa Pharmaceuticals Plc (BDRX) are climbing about 69 percent on Thursday morning trading after it announced a partnership with Syngene International Ltd for the manufacture of both MTX240 active pharmaceutical ingredient and dosage form.

The company's shares are currently trading at $1.05 on the Nasdaq, up 69.49 percent. The stock opened at $0.9235 and has climbed as high as $1.35 so far in today's session. Over the past year, it has traded in a range of $0.6010 to $19.300.

Moreover, the company is planning to file an IND and initiate a Phase 1b/2a study towards the end of the year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.